Guide
Medical device market intelligence
Medical device market intelligence is the practice of scoring and comparing markets on regulatory route, payment and reimbursement, competition, and adoption — so a launch shortlist is built on evidence rather than on the countries a team happens to know.
What medical device market intelligence covers
A market is attractive only when every part of the chain works: the device can be classified and cleared, someone pays for it, a hospital can buy it, and clinicians will use it. Market intelligence puts those dimensions on the same scale so two countries can be compared honestly instead of described separately.
- Regulatory classification and the likely premarket route in each market
- Payment forecasting: coding, coverage, and who ultimately pays
- Procurement, tender cycles, and local representation or distribution requirements
- Competitive density and the incumbent devices already reimbursed
- Clinical adoption readiness and the evidence clinicians expect
How teams use medical device market intelligence
Most teams run the same sequence. The regulatory step usually anchors everything else — see the global FDA pathways guide for 510(k), De Novo and PMA, and the EU MDR and UKCA guide for the European and UK routes.
- 1Score a wide set of markets on the same criteria, with weights that reflect your strategy rather than a generic index.
- 2Shortlist the three or four markets that clear both the regulatory and the payment test.
- 3Go deep on the shortlist: evidence expectations, reimbursement timelines, procurement cycles, and local representation.
- 4Sequence the launches so the evidence generated in the first market supports the next one.
How MedTech Compass delivers medical device market scoring
MedTech Compass applies multi-dimensional market scoring across 25+ markets with custom weights and payment forecasting, and pairs it with MedTech regulatory triage so the regulatory route and the commercial case are assessed together. Every answer is evidence-grounded and exportable as an executive-ready summary — see how MedTech Compass works or read demo cases showing illustrative market scores and outcomes.
Teams usually start with the free Market Signal tier to validate one market question, then move to a launch-ready report. See MedTech Compass and Copilot for tiers, or book a live demo.
Frequently asked questions
- What is medical device market intelligence?
- Medical device market intelligence is the structured practice of scoring and comparing countries on the factors that decide commercial success: device classification and regulatory route, reimbursement and payment, procurement and distribution, competitive density, and clinical adoption readiness. The output is a defensible shortlist of markets rather than an intuition-led guess.
- How is it different from market access?
- Market intelligence is the analysis that decides which markets to pursue. Market access is the execution work that gets a device approved, reimbursed, purchased, and used in the markets you chose. Intelligence comes first and reduces the chance of spending access budget in the wrong country.
- Do small MedTech teams need it?
- Yes, and usually more than large ones. A start-up has budget for one or two launches, so choosing the wrong first market is expensive in a way it is not for a multinational. A wide, shallow scoring pass followed by depth on the top three markets is inexpensive relative to relaunching a study or entering a market that cannot pay for the device.